| 摘要 |
The present invention relates to combinations of A) oxazolidinones of the formula (I) with B) acetylsalicylic acid (aspirin) and C) an ADP receptor antagonist, in particular P2Y12 purino receptor blocker, a process for producing these combinations and the use thereof as medicaments, in particular for the prophylaxis and/or treatment of thromboembolic disorders. ® KIPO & WIPO 2009 |
